- Bengaluru-based early-stage diagnostic company Acculi Labs said that it has secured undisclosed pre-seed funding from a group of angels and Bengaluru-based consultancy and services Startup Basket.
- Acculi Labs will use the funds to complete all the necessary steps needed to secure the IP and certification before mass commercialisation of its product Lyfas.
- Speaking on the investment, Hari Prasath, Co-founder and Chief Business Officer of the Acculi Labs, said, ” We have been not only improving and validating our product over the last two years but also have done several market exploration and field testing.
- According to the startup, the challenge of bringing such a product to the market is – it needs to clear several stages of clinical validation, compliances, and certification which are both time and cost intensive.
Read full article: yourstory.com